Confo Therapeutics raised EUR 60M in a Series B financing led by Ackermans & van Haaren (AvH) to advance pipeline of novel GPCR-modulating therapies into clinical development.
Amount Raised
€60 Million
Round Type
Series B
GhentBiotechnologyInvestors
Description
Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), announced the closing of a EUR 60M Series B financing. The proceeds will be used to advance two wholly owned programs through Phase 1 and two additional programs to IND approval, including molecules targeting GPR75 for obesity.
Quick answer
Confo Therapeutics raised €60 Million in a Series B round, dated July 26, 2024. Investors: Ackermans & Van Haaren, Bio Generation Ventures, Wellington Partners, Vib, V Bio Ventures, Pmv, Qbic and Perceptive Advisors. Confo Therapeutics is based in Ghent, East Flanders, Belgium.
- How much did Confo Therapeutics raise?
- Confo Therapeutics raised €60 Million in a Series B round on July 26, 2024.
- Who invested in Confo Therapeutics?
- Ackermans & Van Haaren, Bio Generation Ventures, Wellington Partners, Vib, V Bio Ventures, Pmv, Qbic and Perceptive Advisors are named as investors in this round.
- What does Confo Therapeutics do?
- Confo Therapeutics is the only GPCR company with a proprietary discovery engine that precisely targets desired GPCR conformations.
- Where is Confo Therapeutics based and how big is it?
- Confo Therapeutics is based in Ghent, East Flanders, Belgium. Fundz records about 51 employees.
- Who are the decision-makers at Confo Therapeutics?
- Fundz holds 1 contact at Confo Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Confo Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Algenie raised $1.1M (Pre-Seed) on September 9, 2024.
- Candid Therapeutics raised $370M (Series A) on September 9, 2024.
- Superluminal Medicines raised $120M (Series A) on September 9, 2024.
- ZipBio raised $4M (Seed) on September 9, 2024.
- Somite raised $4.8M (Pre-Seed) on September 9, 2024.
- Synapticure raised $40M on September 9, 2024.
Who to call at Confo Therapeutics, and when
A new round usually means Confo Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Confo Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Confo Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Confo Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Confo Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansConfo Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.